A C Maas - JoVE Visualize

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Lancet (London, England)|September 21, 1996

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hourE Boersma, A C Maas, J W Deckers, et al.

Nederlands Tijdschrift Voor Geneeskunde|November 7, 2001

[Twelve year triage and thrombolysis treatment prior to hospitalization for myocardial infarction patients in the Rotterdam area of the Netherlands: outstanding short-term and long-term results]E Boersma, A C Maas, J A Hartman, et al.

Journal of the American College of Cardiology|May 1, 1996

Repeat interventions as a long-term treatment strategy in the management of progressive coronary artery diseaseK G Lehmann, A C Maas, R van Domburg, et al.

Journal of Electrocardiology|May 20, 2000

Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyK M Akkerhuis, A C Maas, P A Klootwijk, et al.

Circulation|May 10, 2000

ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapyJ Andrews, I T Straznicky, J K French, et al.

European Heart Journal|May 18, 1999

Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarctionA C Maas, R T van Domburg, J W Deckers, et al.

Journal of the American College of Cardiology|January 12, 2001

Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionM T Roe, E M Ohman, A C Maas, et al.

American Heart Journal|October 31, 2001

Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilotM W Krucoff, S W Crater, C L Green, et al.

Diabetes, Obesity & Metabolism|December 31, 2013

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndromeA M van den Hoek, J W A van der Hoorn, A C Maas, et al.

Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Lancet (London, England)|September 21, 1996

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hourE Boersma, A C Maas, J W Deckers, et al.

Nederlands Tijdschrift Voor Geneeskunde|November 7, 2001

[Twelve year triage and thrombolysis treatment prior to hospitalization for myocardial infarction patients in the Rotterdam area of the Netherlands: outstanding short-term and long-term results]E Boersma, A C Maas, J A Hartman, et al.

Journal of the American College of Cardiology|May 1, 1996

Repeat interventions as a long-term treatment strategy in the management of progressive coronary artery diseaseK G Lehmann, A C Maas, R van Domburg, et al.

Journal of Electrocardiology|May 20, 2000

Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyK M Akkerhuis, A C Maas, P A Klootwijk, et al.

Circulation|May 10, 2000

ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapyJ Andrews, I T Straznicky, J K French, et al.

European Heart Journal|May 18, 1999

Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarctionA C Maas, R T van Domburg, J W Deckers, et al.

Journal of the American College of Cardiology|January 12, 2001

Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionM T Roe, E M Ohman, A C Maas, et al.

American Heart Journal|October 31, 2001

Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilotM W Krucoff, S W Crater, C L Green, et al.

Diabetes, Obesity & Metabolism|December 31, 2013

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndromeA M van den Hoek, J W A van der Hoorn, A C Maas, et al.

Pageof 1